<DOC>
	<DOCNO>NCT01869361</DOCNO>
	<brief_summary>Background : Indomethacin frequently use tocolytic , however currently scant evidence support efficacy . Goals : To delay preterm delivery 48 hour examine longer latency period maternal neonatal outcome Methods : Randomized placebo-controlled trial indomethacin tocolysis . Women singleton pregnancy 23w0d 31w6d preterm labor randomly assign 50mg indomethacin mouth follow 25mg mouth every 6hour 48 hour placebo . Patients receive betamethasone fetal lung maturity , previously administer , magnesium sulfate neuroprotection . Ultrasound perform initiation study drug completion study medication amniotic fluid index fetal cardiac assessment .</brief_summary>
	<brief_title>Indomethacin Tocolysis</brief_title>
	<detailed_description />
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<criteria>Preterm labor define regular uterine contraction ( least 6/hour ) cervical change least 1 cm cervical shorten transvaginal ultrasound le 25mm functional length Gestational age 23w0d 31w6d week Singleton ≥ 18 year old Able consent English Major congenital anomaly associate increase risk newborn death Multiple fetal gestation ( 2+ ) Known intrauterine fetal demise Nonreassuring fetal status require delivery Preterm premature rupture membrane ( PPROM ) Suspected known intrauterine infection Placenta previa Maternal allergy contraindication indomethacin ( peptic ulcer disease , thrombocytopenia , coagulopathy , renal hepatic dysfunction ) Inevitable delivery ( cervix ≥6cm dilate )</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>preterm labor</keyword>
	<keyword>tocolysis</keyword>
	<keyword>indomethacin</keyword>
</DOC>